Supreme Court to hear glyphosate case impacting consumer lawsuits

The U.S. Supreme Court is set to hear arguments this week regarding glyphosate, a weed-killing chemical in the Roundup brand, which has been linked to cancer in various studies. Monsanto, now part of Bayer, is contesting over 100,000 lawsuits alleging it failed to warn consumers about cancer risks associated with glyphosate. The company argues that under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), it cannot be held liable for failing to provide warnings unless the Environmental Protection Agency (EPA) has identified a risk and mandated such warnings. The EPA currently considers glyphosate 'unlikely' to be carcinogenic.

Bayer claims that a favorable ruling would help conclude ongoing litigation. Supporting Monsanto is Syngenta, which faces similar lawsuits regarding its paraquat herbicide linked to Parkinson's disease. Legal experts suggest that a ruling in favor of Monsanto could restrict future lawsuits against other pesticide manufacturers as well. Lawrence Ebner, general counsel for the Atlantic Legal Foundation, stated that excessive warnings could mislead consumers about which risks are significant. Conversely, Jim Jones, a former EPA official, emphasized the importance of state regulation in determining necessary warnings.

The case highlights a divide between the Trump administration, which supports Monsanto, and grassroots health advocates. Trump's solicitor general will argue in favor of Monsanto, while a rally organized by the 'Make America Healthy Again' movement is planned outside the courthouse to protest the company's position. Vani Hari, a health advocate, criticized the administration's alignment with corporate interests over public health, stating, 'People expect leadership that puts their health first.'